Cytotec, Misoprostol Newswire (Page 6)

Cytotec, Misoprostol Newswire (Page 6)

Comprehensive Real-Time News Feed for Cytotec, Misoprostol (generic). (Page 6)

Results 101 - 120 of 435 in Cytotec, Misoprostol (generic)

  1. Eagle Pharmaceuticals Inc. (EGRX) Earns "Neutral" Rating from MizuhoRead the original story w/Photo

    Oct 9, 2016 | AmericanBankingNews.com

    's stock had its "neutral" rating reiterated by analysts at Mizuho in a note issued to investors on Tuesday. They presently have a $47.00 price objective on the specialty pharmaceutical company's stock, up from their previous price objective of $37.80.

    Comment?

  2. Bank of New York Mellon Corp Increases Stake in Eagle Pharmaceuticals Inc.Read the original story w/Photo

    Oct 9, 2016 | Daily Political

    Bank of New York Mellon Corp raised its position in Eagle Pharmaceuticals Inc. by 1.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission . The fund owned 41,540 shares of the specialty pharmaceutical company's stock after buying an additional 658 shares during the period.

    Comment?

  3. Abortion-pill company to seek review that could enable provincial coverageRead the original story w/Photo

    Oct 3, 2016 | The Globe and Mail

    An open drawer of a telemedicine terminal in Des Moines, Iowa, from which Planned Parenthood of the Heartland clinic doctors can remotely prescribe the abortion-inducing drug RU-486, now known as Mifegymiso An open drawer of a telemedicine terminal in Des Moines, Iowa, from which Planned Parenthood of the Heartland clinic doctors can remotely prescribe the abortion-inducing drug RU-486, now known as Mifegymiso In a reversal of course, the company that is bringing the abortion pill to Canada has decided to go ahead with a crucial cost-effectiveness review that could clear the way for provincial drug plans to cover the $300 medication, Health Canada says.

    Comment?

  4. Not a Time to Die: A Story of Birth in UgandaRead the original story w/Photo

    Sep 30, 2016 | Switched

    In a village in the rural Mubende district of Uganda, Annette had a feeling that something was not right with her pregnancy. Like most women in rural Uganda, Annette is a farmer, and works alongside the other wives and mothers in her community to provide food for her family.

    Comment?

  5. Eagle Pharmaceuticals Inc. (EGRX) Given Outperform Rating at RBC Capital MarketsRead the original story w/Photo

    Sep 28, 2016 | Daily Political

    They currently have a $80.00 price target on the specialty pharmaceutical company's stock, up from their previous price target of $78.00. Several other research analysts also recently commented on the company.

    Comment?

  6. Abortion pills in Canada not covered by most provincial drug plansRead the original story

    Sep 27, 2016 | Newkerala.com

    Added to this was the fact that this drug could not be distributed by pharmacists. The requiring physicians who were permitted to distribute Mifegymiso were restricted by the advocacy warnings.

    Comment?

  7. Safe Abortion DayRead the original story w/Photo

    Sep 27, 2016 | Bangkok Post

    At present, doctors must record and report every abortion pill prescription to the Public Health Ministry as required by the Food and Drug Administration. Also, many doctors consider abortion to be a sin.

    Comment?

  8. Why is getting the abortion pill to women such a complicated thing?Read the original story w/Photo

    Sep 26, 2016 | The Globe and Mail

    Mifegyne, the French version of the treatment, first went on sale in France 29 years ago, but was only approved for sale in Canada in 2015. Mifegyne, the French version of the treatment, first went on sale in France 29 years ago, but was only approved for sale in Canada in 2015.

    Comment?

  9. Most provincial drug plans won't cover abortion pills in CanadaRead the original story w/Photo

    Sep 26, 2016 | The Globe and Mail

    An open drawer of a telemedicine terminal in Des Moines, Iowa, from which Planned Parenthood of the Heartland clinic doctors can remotely prescribe the abortion-inducing drug RU-486, is shown on Sept. 22, 2010.

    Comment?

  10. Eagle Pharmaceuticals' (EGRX) Outperform Rating Reaffirmed at RBC Capital MarketsRead the original story w/Photo

    Sep 22, 2016 | AmericanBankingNews.com

    's stock had its "outperform" rating reiterated by equities research analysts at RBC Capital Markets in a research report issued on Thursday. They currently have a $80.00 target price on the specialty pharmaceutical company's stock, up from their previous target price of $78.00.

    Comment?

  11. Oxytocin enhances spirituality, new study saysRead the original story w/Photo

    Sep 21, 2016 | PhysOrg Weblog

    Oxytocin has been dubbed the "love hormone" for its role promoting social bonding, altruism and more. Now new research from Duke University suggests the hormone may also support spirituality.

    Comment?

  12. Eagle Pharmaceuticals Inc. (EGRX) Upgraded by Zacks Investment Research to HoldRead the original story w/Photo

    Sep 20, 2016 | AmericanBankingNews.com

    According to Zacks, "Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States.

    Comment?

  13. Misoprostol doesn't cut risk of postpartum hemorrhageRead the original story w/Photo

    Sep 20, 2016 | PhysOrg Weblog

    For women in the third stage of labor, misoprostol administered with routine oxytocin does not reduce the rate of postpartum hemorrhage, according to a study published online Sept. 5 in Obstetrics & Gynecology .

    Comment?

  14. Eagle Pharmaceuticals Inc. (EGRX) Shares Down 6.2%Read the original story w/Photo

    Sep 13, 2016 | AmericanBankingNews.com

    Eagle Pharmaceuticals Inc. shares fell 6.2% during mid-day trading on Tuesday . The company traded as low as $58.02 and last traded at $58.51, with a volume of 168,201 shares trading hands.

    Comment?

  15. Eagle Pharmaceuticals Inc. (EGRX) Trading Up 3.1%Read the original story w/Photo

    Sep 12, 2016 | AmericanBankingNews.com

    Eagle Pharmaceuticals Inc. was up 3.1% during trading on Monday . The stock traded as high as $62.85 and last traded at $62.06, with a volume of 167,646 shares changing hands.

    Comment?

  16. Eagle Pharmaceuticals Inc. (EGRX) Trading Down 2.4%Read the original story w/Photo

    Sep 7, 2016 | AmericanBankingNews.com

    Eagle Pharmaceuticals Inc. fell 2.4% on Wednesday . The company traded as low as $60.52 and last traded at $60.52, with a volume of 216,928 shares changing hands.

    Comment?

  17. Investors Buy Shares of Eagle Pharmaceuticals Inc. (EGRX) on WeaknessRead the original story w/Photo

    Sep 4, 2016 | Daily Political

    Investors bought shares of Eagle Pharmaceuticals Inc. on weakness during trading hours on Friday. $46.04 million flowed into the stock on the tick-up and $4.71 million flowed out of the stock on the tick-down, for a money net flow of $41.33 million into the stock.

    Comment?

  18. Investors Buy Eagle Pharmaceuticals Inc. (EGRX) on WeaknessRead the original story w/Photo

    Sep 3, 2016 | Daily Political

    Investors bought shares of Eagle Pharmaceuticals Inc. on weakness during trading hours on Thursday. $46.04 million flowed into the stock on the tick-up and $4.71 million flowed out of the stock on the tick-down, for a money net flow of $41.33 million into the stock.

    Comment?

  19. Eagle Pharmaceuticals Inc. (EGRX) Shares Down 1.5%Read the original story w/Photo

    Sep 3, 2016 | Daily Political

    Eagle Pharmaceuticals Inc. fell 1.5% on Thursday . The stock traded as low as $57.48 and last traded at $58.84, with a volume of 148,112 shares traded.

    Comment?

  20. Investors Buy Eagle Pharmaceuticals Inc. (EGRX) on WeaknessRead the original story w/Photo

    Sep 2, 2016 | Daily Political

    Traders bought shares of Eagle Pharmaceuticals Inc. on weakness during trading on Thursday. $46.04 million flowed into the stock on the tick-up and $4.71 million flowed out of the stock on the tick-down, for a money net flow of $41.33 million into the stock.

    Comment?